VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹70 Cr |
Mar2023 | ₹76 Cr |
Mar2022 | ₹5,377,389 Cr |
Mar2021 | ₹60 Cr |
Mar2020 | ₹75 Cr |
How is Revenue of VAISHALI PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹70 Cr | -8.12 | |
Mar2023 | ₹76 Cr | -100.00 | |
Mar2022 | ₹5,377,389 Cr | 8,949,387.00 | |
Mar2021 | ₹60 Cr | -19.98 | |
Mar2020 | ₹75 Cr | - |
Compare Revenue of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹207.0 Cr | -8% | 4.8% | 0.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -8% |
4.8% |
0.5% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses